Insmed | INSM - O Lucro Antes De Impostos

Preço das Ações
154.81
Mudança Diária
-4.78 -3.00%
Mensal
11.05%
Anual
125.77%
Q2 Previsão
150.58




O Lucro Antes De Impostos Alterar Data
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Cytokinetics USD -183.03M 123.15M 2025-12
DBV Technologies USD -33.16M 8.6M 2025-09
Gilead Sciences USD 3.64B 1.21B 2025-09
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -326.93M 41.77M 2025-12
Novartis USD 5.17B 637M 2025-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09